These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33773999)

  • 1. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
    Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
    Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors.
    Kolcheva M; Ladislav M; Netolicky J; Kortus S; Rehakova K; Krausova BH; Hemelikova K; Misiachna A; Kadkova A; Klima M; Chalupska D; Horak M
    Neuropharmacology; 2023 Jan; 222():109297. PubMed ID: 36341805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors.
    Skrenkova K; Song JM; Kortus S; Kolcheva M; Netolicky J; Hemelikova K; Kaniakova M; Krausova BH; Kucera T; Korabecny J; Suh YH; Horak M
    Sci Rep; 2020 Oct; 10(1):18576. PubMed ID: 33122756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo.
    Kaniakova M; Kleteckova L; Lichnerova K; Holubova K; Skrenkova K; Korinek M; Krusek J; Smejkalova T; Korabecny J; Vales K; Soukup O; Horak M
    Neuropharmacology; 2018 Sep; 140():217-232. PubMed ID: 30099049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
    Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
    Chen X; Keramidas A; Harvey RJ; Lynch JW
    Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist.
    McKay S; Griffiths NH; Butters PA; Thubron EB; Hardingham GE; Wyllie DJ
    Br J Pharmacol; 2012 Jun; 166(3):924-37. PubMed ID: 22022974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
    Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
    Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors.
    Skrenkova K; Hemelikova K; Kolcheva M; Kortus S; Kaniakova M; Krausova B; Horak M
    Sci Rep; 2019 Aug; 9(1):12303. PubMed ID: 31444392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
    Yi F; Bhattacharya S; Thompson CM; Traynelis SF; Hansen KB
    J Physiol; 2019 Nov; 597(22):5495-5514. PubMed ID: 31541561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intersubunit interactions at putative sites of ethanol action in the M3 and M4 domains of the NMDA receptor GluN1 and GluN2B subunits.
    Zhao Y; Ren H; Peoples RW
    Br J Pharmacol; 2016 Jun; 173(12):1950-65. PubMed ID: 27010645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of S2-M4 linker coupling reveals novel subunit-specific contributions to N-methyl-d-aspartate receptor function and ethanol sensitivity.
    Hughes BA; Woodward JJ
    Neuropharmacology; 2016 Jun; 105():96-105. PubMed ID: 26577016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GluN2 Subunit-Dependent Redox Modulation of NMDA Receptor Activation by Homocysteine.
    Sibarov DA; Boikov SI; Karelina TV; Antonov SM
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
    Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
    Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
    Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitivity of cerebellar neurons to homocysteine is determined by expression of GluN2C and GluN2D subunits of NMDA receptors.
    Sibarov DA; Giniatullin R; Antonov SM
    Biochem Biophys Res Commun; 2018 Nov; 506(3):648-652. PubMed ID: 30454701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-channel properties of N-methyl-D-aspartate receptors containing chimaeric GluN2A/GluN2D subunits.
    O'Leary T; Wyllie DJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1347-54. PubMed ID: 19909274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.